Current Advances in Nanomaterials Affecting Functions and Morphology of Platelets
Source abstract
Abstract
Nanomaterials have been extensively used in the biomedical field due to their unique physical and chemical properties. They promise wide applications in the diagnosis, prevention, and treatment of diseases. Nanodrugs are generally transported to target tissues or organs by coupling targeting molecules or enhanced permeability and retention effect (EPR) passively. As intravenous injection is the most common means of administration of nanomedicine, the transport process inevitably involves the interactions between nanoparticles (NPs) and blood cells. Platelets are known to not only play a critical role in normal coagulation by performing adhesion, aggregation, release, and contraction functions, but also be associated with pathological thrombosis, tumor metastasis, inflammation, and immune reactions, making it necessary to investigate the effects of NPs on platelet function during transport, particularly the way in which their physical and chemical properties determine their interaction with platelets and the underlying mechanisms by which they activate and induce platelet aggregation. However, such data are lacking. This review is intended to summarize the effects of NPs on platelet activation, aggregation, release, and apoptosis, as well as their effects on membrane proteins and morphology in order to shed light on such key issues as how to reduce their adverse reactions in the blood system, which should be taken into consideration in NP engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Platelet Disorders and Treatments · Nanoparticle-Based Drug Delivery · Blood properties and coagulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Health Service and Transfusion Medicine, Beijing 100850, China
Funding
National Natural Science Foundation of China
References (84)
Show source-provided references
1. Systematic toxicity evaluation of polystyrene nanoplastics on mice and molecular mechanism investigation about their internalization into Caco-2 cells10.1016/j.jhazmat.2021.126092 ↗
2. Liu, Y.Y., Chang, Q., Sun, Z.X., Liu, J., Deng, X., Liu, Y., Cao, A., and Wang, H. (2021). Fate of CdSe/ZnS quantum dots in cells: Endocytosis, translocation and exocytosis. Colloids Surf. B Biointerfaces, 208.10.1016/j.colsurfb.2021.112140 ↗
3. Current advances in nanomaterials affecting morphology, structure, and function of erythrocytes10.1039/D0RA10124A ↗
4. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient10.1111/trf.15079 ↗
5. A Review of the Use of Metallic Nanoparticles as a Novel Approach for Overcoming the Stability Challenges of Blood Products: A Narrative Review from 2011–202110.2174/1567201819666220513092020 ↗
6. Characterization of Antiplatelet Properties of Silver Nanoparticles10.1021/nn900277t ↗
7. On-chip evaluation of platelet adhesion and aggregation upon exposure to mesoporous silica nanoparticles10.1039/C3AN01679J ↗
8. Amorphous silica nanoparticles aggregate human platelets: Potential implications for vascular homeostasis
9. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure10.1088/0957-4484/23/4/045101 ↗
10. Adenosine diphosphate-decorated chitosan nanoparticles shorten blood clotting times, influencing the structures and varying the mechanical properties of the clots10.2147/IJN.S57855 ↗
11. Platelet aggregation induced by polystyrene and platinum nanoparticles is dependent on surface area10.1039/C8RA07315E ↗
12. Induction and enhancement of platelet aggregation in vitro and in vivo by model polystyrene nanoparticles10.3109/17435390.2014.933902 ↗
13. Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation10.2174/0929867323666160106151428 ↗
14. The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces10.1016/j.biomaterials.2012.01.005 ↗
15. Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy10.1073/pnas.1901987116 ↗
16. Anti-Platelet Effect Induced by Iron Oxide Nanoparticles: Correlation with Conformational Change in Fibrinogen10.1002/smll.202004945 ↗
17. Sialic Acid: Its importance to platelet function in health and disease10.3109/09537109109005496 ↗
18. Platelet sialic acid and platelet survival after aggregation by ADP10.1182/blood.V56.5.876.876 ↗
19. Platelet activation by charged ligands and nanoparticles: Platelet glycoprotein receptors as pattern recognition receptors10.1080/09537104.2021.1945571 ↗
20. Controlling Surface-Induced Platelet Activation by Agarose and Gelatin-Based Hydrogel Films10.1021/acsomega.1c00764 ↗
21. CdTe quantum dots induce activation of human platelets: Implications for nanoparticle hemocompatibility
22. Cationic PAMAM dendrimers disrupt key platelet functions10.1021/mp2006054 ↗
23. Intravenous hemostat: Nanotechnology to halt bleeding10.1126/scitranslmed.3000397 ↗
24. Cao, J., Yang, P., Wang, P., Xu, S., Cheng, Y., Qian, K., Xu, M., Sheng, D., Li, Y., and Wei, Y. (2021). ‘Adhesion and release’ nanoparticle-mediated efficient inhibition of platelet activation disrupts endothelial barriers for enhanced drug delivery in tumors. Biomaterials, 269.10.1016/j.biomaterials.2020.120620 ↗
25. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases10.1155/2013/734509 ↗
26. Platelet Extracellular Vesicles: Beyond the Blood10.1161/ATVBAHA.120.314644 ↗
27. Platelet-adenovirus vs. inert particles interaction: Effect on aggregation and the role of platelet membrane receptors10.3109/09537104.2012.703792 ↗
28. Galdino, F.E., Picco, A.S., Sforca, M.L., Cardoso, M.B., and Loh, W. (2020). Effect of particle functionalization and solution properties on the adsorption of bovine serum albumin and lysozyme onto silica nanoparticles. Colloids Surf. B Biointerfaces, 186.10.1016/j.colsurfb.2019.110677 ↗
29. Li, L., Yang, Y., Wang, L., Xu, F., Li, Y., and He, X. (2023). The effects of serum albumin pre-adsorption of nanoparticles on protein corona and membrane interaction: A molecular simulation study. J. Mol. Biol., 435.10.1016/j.jmb.2022.167771 ↗
30. Gold nanoparticles with different amino acid surfaces: Serum albumin adsorption, intracellular uptake and cytotoxicity10.1016/j.colsurfb.2014.10.042 ↗
31. Magnetic Nanoparticle Labeling of Human Platelets from Platelet Concentrates for Recovery and Survival Studies10.1021/acsami.7b10113 ↗
32. Silica Nanoparticle-Endothelial Interaction: Uptake and Effect on Platelet Adhesion under Flow Conditions10.1021/acsabm.8b00466 ↗
33. The role of von Willebrand factor in thrombus formation10.1016/j.thromres.2007.03.011 ↗
34. Immunoliposomal drug-delivery system targeting lectin-like oxidized low-density lipoprotein receptor-1 for carotid plaque lesions in rats10.3171/2011.5.JNS10227 ↗
35. Mildly oxidized HDL decrease agonist-induced platelet aggregation and release of pro-coagulant platelet extracellular vesicles10.1016/j.jsbmb.2016.05.003 ↗
36. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo10.1161/CIRCRESAHA.115.306901 ↗
37. Silver nano particles prevent platelet adhesion on immobilized fibrinogen10.1007/s12291-011-0169-4 ↗
38. The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation
39. P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions10.1055/s-0042-1758655 ↗
40. Platelet surface marker analysis by mass cytometry10.1080/09537104.2019.1668549 ↗
41. Platelet adhesion to collagen type I, collagen type IV, von Willebrand factor, fibronectin, laminin and fibrinogen: Rapid kinetics under shear10.1055/s-0037-1614428 ↗
42. Platelet Integrin αIIbβ3-Ligand Interactions: What Can We Learn From the Structure?10.1007/BF02982080 ↗
43. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets10.1182/blood.V88.3.907.907 ↗
44. Platelet integrin alphaIIbbeta3: Signal transduction, regulation, and its therapeutic targeting10.1186/s13045-019-0709-6 ↗
45. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood10.1016/j.biomaterials.2009.03.054 ↗
46. The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins10.1016/j.biomaterials.2011.05.062 ↗
47. PolySTAT-modified chitosan gauzes for improved hemostasis in external hemorrhage10.1016/j.actbio.2015.11.017 ↗
48. Gallium-containing mesoporous bioactive glass with potent hemostatic activity and antibacterial efficacy10.1039/C5TB02062J ↗
49. Microspheres of carboxymethyl chitosan, sodium alginate and collagen for a novel hemostatic in vitro study10.1177/0885328215618354 ↗
50. A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing10.1039/C7RA13510F ↗
51. Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles10.1002/jbm.a.34591 ↗
52. Nanoparticle-induced platelet aggregation and vascular thrombosis10.1038/sj.bjp.0706386 ↗
53. Platelet granule secretion continuously prevents intratumor hemorrhage10.1158/0008-5472.CAN-08-0718 ↗
54. Targeting platelet function to improve drug delivery10.4161/onci.1.1.17962 ↗
55. Effects and treatment applications of polymeric nanoparticles on improving platelets’ storage time: A review of the literature from 2010 to 202010.5045/br.2021.2021094 ↗
56. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro10.1021/mp200463e ↗
57. Cationic PAMAM dendrimers aggressively initiate blood clot formation10.1021/nn303472r ↗
58. Anionic linear-globular dendrimers: Biocompatible hybrid materials with potential uses in nanomedicine10.1007/s10856-009-3978-8 ↗
59. Comprehensive investigation of in vitro hemocompatibility of surface modified polyamidoamine nanocarrier10.3233/CH-190641 ↗
60. Association of Methotrexate with Native and PEGylated PAMAM-G4 Dendrimers: Effect of the PEGylation Degree on the Drug-Loading Capacity and Preferential Binding Sites10.1021/acs.jpcb.6b08882 ↗
61. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin10.1080/10837450.2017.1315134 ↗
62. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery10.1016/j.actbio.2016.07.015 ↗
63. Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles10.1016/j.nano.2016.10.010 ↗
64. Bakhaidar, R., O’Neill, S., and Ramtoola, Z. (2020). PLGA-PEG Nanoparticles Show Minimal Risks of Interference with Platelet Function of Human Platelet-Rich Plasma. Int. J. Mol. Sci., 21.10.3390/ijms21249716 ↗
65. Bakhaidar, R., Green, J., Alfahad, K., Samanani, S., Moollan, N., O’Neill, S., and Ramtoola, Z. (2019). Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets. Pharmaceutics, 11.10.3390/pharmaceutics11100514 ↗
66. Dual-functionalized poly(amidoamine) dendrimers with poly(ethylene glycol) conjugation and thiolation improved blood compatibility10.1111/jphp.12457 ↗
67. Ahmed, M., Kurungottu, P.A.-O., Swetha, K.A.-O., Atla, S.A.-O., Ashok, N.A.-O.X., Nagamalleswari, E.A.-O., Bonam, S.A.-O., Sahu, B.A.-O., and Kurapati, R.A.-O. (2024). Role of NLRP3 inflammasome in nanoparticle adjuvant-mediated immune response. Biomater. Sci., online ahead of print.10.1039/D4BM00439F ↗
68. Silica nanoparticles induce lung inflammation in mice via ROS/PARP/TRPM2 signaling-mediated lysosome impairment and autophagy dysfunction10.1186/s12989-020-00353-3 ↗
69. Platelet-lymphocyte co-culture serves as an ex vivo platform of dynamic heterotypic cross-talk10.1007/s12079-022-00676-0 ↗
70. Impaired Platelet Response to Thromboxane-A2 and Defective Calcium Mobilization in a Patient With a Bleeding Disorder10.1182/blood.V57.3.545.545 ↗
71. Potter, T.M., Rodriguez, J.C., Neun, B.W., Ilinskaya, A.N., Cedrone, E., and Dobrovolskaia, M.A. (2018). In Vitro Assessment of Nanoparticle Effects on Blood Coagulation. Characterization of Nanoparticles Intended for Drug Delivery, Humana Press.10.1007/978-1-4939-7352-1_10 ↗
72. Effect of nano-scale curvature on the intrinsic blood coagulation system10.1039/C4NR04128C ↗
73. Release of α-granule contents during platelet activation10.1080/09537104.2021.1913576 ↗
74. Montecino-Garrido, H., Mendez, D., Araya-Maturana, R., Millas-Vargas, J.P., Wehinger, S., and Fuentes, E. (2022). In Vitro Effect of Mitochondria-Targeted Triphenylphosphonium-Based Compounds (Honokiol, Lonidamine, and Atovaquone) on the Platelet Function and Cytotoxic Activity. Front. Pharmacol., 13.10.3389/fphar.2022.893873 ↗
75. Platelet intrinsic apoptosis10.1016/j.thromres.2022.11.024 ↗
76. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets10.1182/blood-2011-04-347849 ↗
77. Synthesis and Cytotoxicity of Y(2)O(3) Nanoparticles of Various Morphologies10.1007/s11671-009-9445-0 ↗
78. Assessment of intermittent exposure of zinc oxide nanoparticle (ZNP)-mediated toxicity and biochemical alterations in the splenocytes of male Wistar rat10.1007/s11356-019-06225-4 ↗
79. Global Burden of Thrombosis: Epidemiologic Aspects10.1161/CIRCRESAHA.115.306841 ↗
80. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth10.1172/JCI29967 ↗
81. Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk10.1016/j.phymed.2022.154271 ↗
82. Integrins take partners: Cross-talk between integrins and other membrane receptors10.1016/S0962-8924(98)01344-0 ↗
83. Construction and characterization of an antibacterial/anticoagulant dual-functional surface based on poly l-lactic acid electrospun fibrous mats10.1016/j.msec.2018.07.014 ↗
84. Zein nanospheres assisting inorganic and organic drug combination to overcome stent implantation-induced thrombosis and infection10.1016/j.scitotenv.2023.162438 ↗